Bromday®

Bromfenac (0.09%)
ophthalmic solution
NSAID
[ Nonsteroidal Anti-inflammatory Drug]
Indication

Indication

Treatment of postoperative inflammation and reduction of ocular pain in cataract surgery patients
Mechanism of Action

Mechanism of Action

Bromfenac inhibits cyclooxygenase 1 and 2, blocking prostaglandin synthesis. This reduces inflammation and pain in the eye, particularly after surgery.
Common quantities available

Available Quantities

1.7 ml
Dosage

Dosage/Instructions

One drop to the affected eye(s) once daily beginning 1 day prior to cataract surgery, continued on the day of surgery, and through the first 14 days of the postoperative period
Pregnancy & Nursing Data

Pregnancy & Nursing

Use during pregnancy only if the potential benefit justifies the potential risk. Unknown if excreted in breast milk.
Pediatric Use

Pediatric Use

No studies
Warnings Tab

Contraindications, side effects, etc.

Contraindications: Hypersensitivity to bromfenac or related NSAIDs. It is also contraindicated in patients with a history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs. Warnings: Bromfenac may cause stinging or burning upon instillation and may temporarily blur vision. Systemic absorption can occur, potentially leading to systemic side effects. Prolonged use should be avoided. Common Side Effects: Common side effects include stinging or burning sensation, transient blurred vision, and increased redness in the eye.